Catastrophic antiphospholipid syndrome market to reach $6.17B by 2029 at 10.4% CAGR, driven by autoimmune prevalence, AI diagnostics, and biologic advances.
Read More
Canine atopic dermatitis market to hit $4.09B by 2029 at 10.3% CAGR, driven by telemedicine, AI diagnostics, monoclonal therapies, and pet care innovation.
Read More
Cancer treatment facilities market to reach $65.44B by 2029 at 7.9% CAGR, driven by personalized medicine, AI integration, and advanced cancer care tech.
Read More
CGRP receptor antagonist market to hit $3.48B by 2029 at 11% CAGR, driven by migraine therapy adoption, oral drugs, long-acting injectables, and nanotech.
Read More
How Will The Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Expand At A CAGR Of 13.5% Through 2029?
BTK inhibitor market to reach $19.18B by 2029 at 13.6% CAGR, driven by autoimmune treatment demand, combo therapies, and advanced drug design innovations.
Read More
Breast ultrasound market to hit $4.96B by 2029 at 12.6% CAGR, driven by AI integration, portable devices, 3D/4D imaging, and tele-imaging adoption.
Read More
Breast reconstruction market to hit $0.79B by 2029 at 6.7% CAGR, driven by surgery demand, advanced meshes, 3D-printed scaffolds, and minimally invasive techniques.
Read More
Bowel stimulator market to reach $1.57B by 2029 at 8.7% CAGR, driven by minimally invasive therapies, neuromodulation advances, and rising bowel care demand.
Read More
Bipolar electrosurgical devices market to hit $8.37B by 2029 at 9.9% CAGR, driven by safer surgical tools, aging population, and advanced device tech.
Read More
Biotech & pharma services outsourcing market to reach $94.91B by 2029 at 7.2% CAGR, driven by faster drug approvals, global trials, and AI adoption.
Read More